New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7.org/fhir/ValueSet/vaccine-code | Version: 0.1.0 | |||
| Standards status: Draft | Maturity Level: 1 | Computable Name: VaccineAdministeredValueSet | ||
| Other Identifiers: OID:2.16.840.1.113883.3.88.12.80.22 | ||||
This identifies the vaccine substance administered - CVX codes.
References
Generated Narrative: ValueSet vaccine-code
version: versionId: id (PrimitiveType/ValueSet.meta.versionId): native = id -> 1; Last updated: 2024-07-25 17:27:15+1200
Profile: Shareable ValueSet
http://hl7.org/fhir/sid/cvx
Generated Narrative: ValueSet
version: versionId: id (PrimitiveType/ValueSet.meta.versionId): native = id -> 1; Last updated: 2024-07-25 17:27:15+1200
Profile: Shareable ValueSet
Expansion based on codesystem Vaccine Administered Code Set (CVX) v0.1.0 (CodeSystem)
This value set contains 273 concepts
| Code | System | Display | Definition |
| 54 | http://hl7.org/fhir/sid/cvx | adenovirus, type 4 | adenovirus vaccine, type 4, live, oral |
| 55 | http://hl7.org/fhir/sid/cvx | adenovirus, type 7 | adenovirus vaccine, type 7, live, oral |
| 82 | http://hl7.org/fhir/sid/cvx | adenovirus, unspecified formulation | adenovirus vaccine, unspecified formulation |
| 24 | http://hl7.org/fhir/sid/cvx | Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis | Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis |
| 19 | http://hl7.org/fhir/sid/cvx | BCG | Bacillus Calmette-Guerin vaccine |
| 27 | http://hl7.org/fhir/sid/cvx | botulinum antitoxin | botulinum antitoxin |
| 26 | http://hl7.org/fhir/sid/cvx | cholera, unspecified formulation | cholera vaccine, unspecified formulation |
| 29 | http://hl7.org/fhir/sid/cvx | CMVIG | cytomegalovirus immune globulin, intravenous |
| 56 | http://hl7.org/fhir/sid/cvx | dengue fever tetravalent | dengue fever vaccine, tetravalent |
| 12 | http://hl7.org/fhir/sid/cvx | diphtheria antitoxin | diphtheria antitoxin |
| 28 | http://hl7.org/fhir/sid/cvx | DT (pediatric) | diphtheria and tetanus toxoids, adsorbed for pediatric use |
| 20 | http://hl7.org/fhir/sid/cvx | DTaP | diphtheria, tetanus toxoids and acellular pertussis vaccine |
| 106 | http://hl7.org/fhir/sid/cvx | DTaP, 5 pertussis antigens | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
| 107 | http://hl7.org/fhir/sid/cvx | DTaP, unspecified formulation | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |
| 110 | http://hl7.org/fhir/sid/cvx | DTaP-Hep B-IPV | DTaP-hepatitis B and poliovirus vaccine |
| 50 | http://hl7.org/fhir/sid/cvx | DTaP-Hib | DTaP-Haemophilus influenzae type b conjugate vaccine |
| 120 | http://hl7.org/fhir/sid/cvx | DTaP-Hib-IPV | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
| 130 | http://hl7.org/fhir/sid/cvx | DTaP-IPV | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
| 1 | http://hl7.org/fhir/sid/cvx | DTP | diphtheria, tetanus toxoids and pertussis vaccine |
| 22 | http://hl7.org/fhir/sid/cvx | DTP-Hib | DTP-Haemophilus influenzae type b conjugate vaccine |
| 102 | http://hl7.org/fhir/sid/cvx | DTP-Hib-Hep B | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
| 57 | http://hl7.org/fhir/sid/cvx | hantavirus | hantavirus vaccine |
| 52 | http://hl7.org/fhir/sid/cvx | Hep A, adult | hepatitis A vaccine, adult dosage |
| 83 | http://hl7.org/fhir/sid/cvx | Hep A, ped/adol, 2 dose | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
| 84 | http://hl7.org/fhir/sid/cvx | Hep A, ped/adol, 3 dose | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
| 31 | http://hl7.org/fhir/sid/cvx | Hep A, pediatric, unspecified formulation | hepatitis A vaccine, pediatric dosage, unspecified formulation |
| 85 | http://hl7.org/fhir/sid/cvx | Hep A, unspecified formulation | hepatitis A vaccine, unspecified formulation |
| 104 | http://hl7.org/fhir/sid/cvx | Hep A-Hep B | hepatitis A and hepatitis B vaccine |
| 30 | http://hl7.org/fhir/sid/cvx | HBIG | hepatitis B immune globulin |
| 8 | http://hl7.org/fhir/sid/cvx | Hep B, adolescent or pediatric | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
| 42 | http://hl7.org/fhir/sid/cvx | Hep B, adolescent/high risk infant | hepatitis B vaccine, adolescent/high risk infant dosage |
| 43 | http://hl7.org/fhir/sid/cvx | Hep B, adult | hepatitis B vaccine, adult dosage |
| 44 | http://hl7.org/fhir/sid/cvx | Hep B, dialysis | hepatitis B vaccine, dialysis patient dosage |
| 45 | http://hl7.org/fhir/sid/cvx | Hep B, unspecified formulation | hepatitis B vaccine, unspecified formulation |
| 58 | http://hl7.org/fhir/sid/cvx | Hep C | hepatitis C vaccine |
| 59 | http://hl7.org/fhir/sid/cvx | Hep E | hepatitis E vaccine |
| 60 | http://hl7.org/fhir/sid/cvx | herpes simplex 2 | herpes simplex virus, type 2 vaccine |
| 46 | http://hl7.org/fhir/sid/cvx | Hib (PRP-D) | Haemophilus influenzae type b vaccine, PRP-D conjugate |
| 47 | http://hl7.org/fhir/sid/cvx | Hib (HbOC) | Haemophilus influenzae type b vaccine, HbOC conjugate |
| 48 | http://hl7.org/fhir/sid/cvx | Hib (PRP-T) | Haemophilus influenzae type b vaccine, PRP-T conjugate |
| 49 | http://hl7.org/fhir/sid/cvx | Hib (PRP-OMP) | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
| 17 | http://hl7.org/fhir/sid/cvx | Hib, unspecified formulation | Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
| 51 | http://hl7.org/fhir/sid/cvx | Hib-Hep B | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
| 61 | http://hl7.org/fhir/sid/cvx | HIV | human immunodeficiency virus vaccine |
| 118 | http://hl7.org/fhir/sid/cvx | HPV, bivalent | human papilloma virus vaccine, bivalent |
| 62 | http://hl7.org/fhir/sid/cvx | HPV, quadrivalent | human papilloma virus vaccine, quadrivalent |
| 86 | http://hl7.org/fhir/sid/cvx | IG | immune globulin, intramuscular |
| 87 | http://hl7.org/fhir/sid/cvx | IGIV | immune globulin, intravenous |
| 14 | http://hl7.org/fhir/sid/cvx | IG, unspecified formulation | immune globulin, unspecified formulation |
| 111 | http://hl7.org/fhir/sid/cvx | influenza, live, intranasal | influenza virus vaccine, live, attenuated, for intranasal use |
| 15 | http://hl7.org/fhir/sid/cvx | influenza, split (incl. purified surface antigen) | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |
| 16 | http://hl7.org/fhir/sid/cvx | influenza, whole | influenza virus vaccine, whole virus |
| 88 | http://hl7.org/fhir/sid/cvx | influenza, unspecified formulation | influenza virus vaccine, unspecified formulation |
| 123 | http://hl7.org/fhir/sid/cvx | influenza, H5N1-1203 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |
| 10 | http://hl7.org/fhir/sid/cvx | IPV | poliovirus vaccine, inactivated |
| 2 | http://hl7.org/fhir/sid/cvx | OPV | trivalent poliovirus vaccine, live, oral |
| 89 | http://hl7.org/fhir/sid/cvx | polio, unspecified formulation | poliovirus vaccine, unspecified formulation |
| 39 | http://hl7.org/fhir/sid/cvx | Japanese encephalitis SC | Japanese Encephalitis Vaccine SC |
| 63 | http://hl7.org/fhir/sid/cvx | Junin virus | Junin virus vaccine |
| 64 | http://hl7.org/fhir/sid/cvx | leishmaniasis | leishmaniasis vaccine |
| 65 | http://hl7.org/fhir/sid/cvx | leprosy | leprosy vaccine |
| 66 | http://hl7.org/fhir/sid/cvx | Lyme disease | Lyme disease vaccine |
| 3 | http://hl7.org/fhir/sid/cvx | MMR | measles, mumps and rubella virus vaccine |
| 4 | http://hl7.org/fhir/sid/cvx | M/R | measles and rubella virus vaccine |
| 94 | http://hl7.org/fhir/sid/cvx | MMRV | measles, mumps, rubella, and varicella virus vaccine |
| 67 | http://hl7.org/fhir/sid/cvx | malaria | malaria vaccine |
| 5 | http://hl7.org/fhir/sid/cvx | measles | measles virus vaccine |
| 68 | http://hl7.org/fhir/sid/cvx | melanoma | melanoma vaccine |
| 32 | http://hl7.org/fhir/sid/cvx | meningococcal MPSV4 | meningococcal polysaccharide vaccine (MPSV4) |
| 103 | http://hl7.org/fhir/sid/cvx | meningococcal C conjugate | meningococcal C conjugate vaccine |
| 114 | http://hl7.org/fhir/sid/cvx | meningococcal MCV4P | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |
| 108 | http://hl7.org/fhir/sid/cvx | meningococcal ACWY, unspecified formulation | meningococcal ACWY vaccine, unspecified formulation |
| 7 | http://hl7.org/fhir/sid/cvx | mumps | mumps virus vaccine |
| 69 | http://hl7.org/fhir/sid/cvx | parainfluenza-3 | parainfluenza-3 virus vaccine |
| 11 | http://hl7.org/fhir/sid/cvx | pertussis | pertussis vaccine |
| 23 | http://hl7.org/fhir/sid/cvx | plague | plague vaccine |
| 33 | http://hl7.org/fhir/sid/cvx | pneumococcal polysaccharide PPV23 | pneumococcal polysaccharide vaccine, 23 valent |
| 100 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate PCV 7 | pneumococcal conjugate vaccine, 7 valent |
| 109 | http://hl7.org/fhir/sid/cvx | pneumococcal, unspecified formulation | pneumococcal vaccine, unspecified formulation |
| 70 | http://hl7.org/fhir/sid/cvx | Q fever | Q fever vaccine |
| 18 | http://hl7.org/fhir/sid/cvx | rabies, intramuscular injection | rabies vaccine, for intramuscular injection RETIRED CODE |
| 40 | http://hl7.org/fhir/sid/cvx | rabies, intradermal injection | rabies vaccine, for intradermal injection |
| 90 | http://hl7.org/fhir/sid/cvx | rabies, unspecified formulation | rabies vaccine, unspecified formulation |
| 72 | http://hl7.org/fhir/sid/cvx | rheumatic fever | rheumatic fever vaccine |
| 73 | http://hl7.org/fhir/sid/cvx | Rift Valley fever | Rift Valley fever vaccine |
| 34 | http://hl7.org/fhir/sid/cvx | RIG | rabies immune globulin |
| 119 | http://hl7.org/fhir/sid/cvx | rotavirus, monovalent | rotavirus, live, monovalent vaccine |
| 122 | http://hl7.org/fhir/sid/cvx | rotavirus, unspecified formulation | rotavirus vaccine, unspecified formulation |
| 116 | http://hl7.org/fhir/sid/cvx | rotavirus, pentavalent | rotavirus, live, pentavalent vaccine |
| 74 | http://hl7.org/fhir/sid/cvx | rotavirus, tetravalent | rotavirus, live, tetravalent vaccine |
| 71 | http://hl7.org/fhir/sid/cvx | RSV-IGIV | respiratory syncytial virus immune globulin, intravenous |
| 93 | http://hl7.org/fhir/sid/cvx | RSV-MAb | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
| 6 | http://hl7.org/fhir/sid/cvx | rubella | rubella virus vaccine |
| 38 | http://hl7.org/fhir/sid/cvx | rubella/mumps | rubella and mumps virus vaccine |
| 76 | http://hl7.org/fhir/sid/cvx | Staphylococcus bacterio lysate | Staphylococcus bacteriophage lysate |
| 113 | http://hl7.org/fhir/sid/cvx | Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
| 9 | http://hl7.org/fhir/sid/cvx | Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
| 115 | http://hl7.org/fhir/sid/cvx | Tdap | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
| 35 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, adsorbed | tetanus toxoid, adsorbed |
| 112 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, unspecified formulation | tetanus toxoid, unspecified formulation |
| 77 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis vaccine (non-US) | Tick-borne encephalitis vaccine (non-US) |
| 13 | http://hl7.org/fhir/sid/cvx | TIG | tetanus immune globulin |
| 95 | http://hl7.org/fhir/sid/cvx | TST-OT tine test | tuberculin skin test; old tuberculin, multipuncture device |
| 96 | http://hl7.org/fhir/sid/cvx | TST-PPD intradermal | tuberculin skin test; purified protein derivative solution, intradermal |
| 97 | http://hl7.org/fhir/sid/cvx | TST-PPD tine test | tuberculin skin test; purified protein derivative, multipuncture device |
| 98 | http://hl7.org/fhir/sid/cvx | TST, unspecified formulation | tuberculin skin test; unspecified formulation |
| 78 | http://hl7.org/fhir/sid/cvx | tularemia vaccine | tularemia vaccine |
| 91 | http://hl7.org/fhir/sid/cvx | typhoid, unspecified formulation | typhoid vaccine, unspecified formulation |
| 25 | http://hl7.org/fhir/sid/cvx | typhoid, oral | typhoid vaccine, live, oral |
| 41 | http://hl7.org/fhir/sid/cvx | typhoid, parenteral | typhoid vaccine, parenteral, other than acetone-killed, dried |
| 53 | http://hl7.org/fhir/sid/cvx | typhoid, parenteral, AKD (U.S. military) | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
| 101 | http://hl7.org/fhir/sid/cvx | typhoid, ViCPs | typhoid Vi capsular polysaccharide vaccine |
| 75 | http://hl7.org/fhir/sid/cvx | vaccinia (smallpox) | vaccinia (smallpox) vaccine |
| 105 | http://hl7.org/fhir/sid/cvx | vaccinia (smallpox) diluted | vaccinia (smallpox) vaccine, diluted |
| 79 | http://hl7.org/fhir/sid/cvx | vaccinia immune globulin | vaccinia immune globulin |
| 21 | http://hl7.org/fhir/sid/cvx | varicella | varicella virus vaccine |
| 81 | http://hl7.org/fhir/sid/cvx | VEE, inactivated | Venezuelan equine encephalitis, inactivated |
| 80 | http://hl7.org/fhir/sid/cvx | VEE, live | Venezuelan equine encephalitis, live, attenuated |
| 92 | http://hl7.org/fhir/sid/cvx | VEE, unspecified formulation | Venezuelan equine encephalitis vaccine, unspecified formulation |
| 36 | http://hl7.org/fhir/sid/cvx | VZIG | varicella zoster immune globulin |
| 117 | http://hl7.org/fhir/sid/cvx | VZIG (IND) | varicella zoster immune globulin (Investigational New Drug) |
| 37 | http://hl7.org/fhir/sid/cvx | yellow fever live | yellow fever vaccine live |
| 121 | http://hl7.org/fhir/sid/cvx | zoster live | zoster vaccine, live |
| 998 | http://hl7.org/fhir/sid/cvx | no vaccine administered | no vaccine administered |
| 999 | http://hl7.org/fhir/sid/cvx | unknown | unknown vaccine or immune globulin |
| 99 | http://hl7.org/fhir/sid/cvx | RESERVED - do not use | RESERVED - do not use |
| 133 | http://hl7.org/fhir/sid/cvx | Pneumococcal conjugate PCV 13 | pneumococcal conjugate vaccine, 13 valent |
| 134 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis IM | Japanese Encephalitis vaccine for intramuscular administration |
| 137 | http://hl7.org/fhir/sid/cvx | HPV, unspecified formulation | HPV, unspecified formulation |
| 136 | http://hl7.org/fhir/sid/cvx | Meningococcal MCV4O | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |
| 135 | http://hl7.org/fhir/sid/cvx | Influenza, high dose seasonal | influenza, high dose seasonal, preservative-free |
| 131 | http://hl7.org/fhir/sid/cvx | typhus, historical | Historical record of a typhus vaccination |
| 132 | http://hl7.org/fhir/sid/cvx | DTaP-IPV-HIB-HEP B, historical | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |
| 128 | http://hl7.org/fhir/sid/cvx | Novel Influenza-H1N1-09, all formulations | Novel influenza-H1N1-09, all formulations |
| 125 | http://hl7.org/fhir/sid/cvx | Novel Influenza-H1N1-09, nasal | Novel Influenza-H1N1-09, live virus for nasal administration |
| 126 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, preservative-free | Novel influenza-H1N1-09, preservative-free, injectable |
| 127 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09 | Novel influenza-H1N1-09, injectable |
| 138 | http://hl7.org/fhir/sid/cvx | Td (adult) | tetanus and diphtheria toxoids, not adsorbed, for adult use |
| 139 | http://hl7.org/fhir/sid/cvx | Td(adult) unspecified formulation | Td(adult) unspecified formulation |
| 140 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable, preservative free | Influenza, seasonal, injectable, preservative free |
| 129 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis, unspecified formulation | Japanese Encephalitis vaccine, unspecified formulation |
| 141 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable | Influenza, seasonal, injectable |
| 142 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, not adsorbed | tetanus toxoid, not adsorbed |
| 143 | http://hl7.org/fhir/sid/cvx | Adenovirus types 4 and 7 | Adenovirus, type 4 and type 7, live, oral |
| 144 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, intradermal, preservative free | seasonal influenza, intradermal, preservative free |
| 145 | http://hl7.org/fhir/sid/cvx | RSV-MAb (new) | respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular |
| 146 | http://hl7.org/fhir/sid/cvx | DTaP,IPV,Hib,HepB | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
| 147 | http://hl7.org/fhir/sid/cvx | meningococcal MCV4, unspecified formulation | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |
| 148 | http://hl7.org/fhir/sid/cvx | Meningococcal C/Y-HIB PRP | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
| 149 | http://hl7.org/fhir/sid/cvx | influenza, live, intranasal, quadrivalent | influenza, live, intranasal, quadrivalent |
| 150 | http://hl7.org/fhir/sid/cvx | influenza, injectable, quadrivalent, preservative free | Influenza, injectable, quadrivalent, preservative free |
| 151 | http://hl7.org/fhir/sid/cvx | influenza nasal, unspecified formulation | influenza nasal, unspecified formulation |
| 152 | http://hl7.org/fhir/sid/cvx | Pneumococcal Conjugate, unspecified formulation | Pneumococcal Conjugate, unspecified formulation |
| 153 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, MDCK, preservative free | Influenza, injectable, Madin Darby Canine Kidney, preservative free |
| 154 | http://hl7.org/fhir/sid/cvx | Hep A, IG | Hepatitis A immune globulin |
| 155 | http://hl7.org/fhir/sid/cvx | influenza, recombinant, injectable, preservative free | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
| 156 | http://hl7.org/fhir/sid/cvx | Rho(D)-IG | Rho(D) Immune globulin- IV or IM |
| 157 | http://hl7.org/fhir/sid/cvx | Rho(D) -IG IM | Rho(D) Immune globulin - IM |
| 158 | http://hl7.org/fhir/sid/cvx | influenza, injectable, quadrivalent | influenza, injectable, quadrivalent, contains preservative |
| 159 | http://hl7.org/fhir/sid/cvx | Rho(D) - Unspecified formulation | Rho(D) Unspecified formulation |
| 160 | http://hl7.org/fhir/sid/cvx | Influenza A monovalent (H5N1), ADJUVANTED-2013 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
| 801 | http://hl7.org/fhir/sid/cvx | AS03 Adjuvant | AS03 Adjuvant |
| 161 | http://hl7.org/fhir/sid/cvx | Influenza, injectable,quadrivalent, preservative free, pediatric | Influenza, injectable,quadrivalent, preservative free, pediatric |
| 162 | http://hl7.org/fhir/sid/cvx | meningococcal B, recombinant | meningococcal B vaccine, fully recombinant |
| 163 | http://hl7.org/fhir/sid/cvx | meningococcal B, OMV | meningococcal B vaccine, recombinant, OMV, adjuvanted |
| 164 | http://hl7.org/fhir/sid/cvx | meningococcal B, unspecified | meningococcal B, unspecified formulation |
| 165 | http://hl7.org/fhir/sid/cvx | HPV9 | Human Papillomavirus 9-valent vaccine |
| 166 | http://hl7.org/fhir/sid/cvx | influenza, intradermal, quadrivalent, preservative free | influenza, intradermal, quadrivalent, preservative free, injectable |
| 167 | http://hl7.org/fhir/sid/cvx | meningococcal, unknown serogroups | meningococcal vaccine of unknown formulation and unknown serogroups |
| 168 | http://hl7.org/fhir/sid/cvx | influenza, trivalent, adjuvanted | Seasonal trivalent influenza vaccine, adjuvanted, preservative free |
| 169 | http://hl7.org/fhir/sid/cvx | Hep A, live attenuated | Hep A, live attenuated-IM |
| 170 | http://hl7.org/fhir/sid/cvx | DTAP/IPV/HIB - non-US | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
| 171 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, MDCK, preservative free, quadrivalent | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |
| 172 | http://hl7.org/fhir/sid/cvx | cholera, WC-rBS | cholera, WC-rBS |
| 173 | http://hl7.org/fhir/sid/cvx | cholera, BivWC | cholera, BivWC |
| 174 | http://hl7.org/fhir/sid/cvx | cholera, live attenuated | cholera, live attenuated |
| 175 | http://hl7.org/fhir/sid/cvx | Rabies - IM Diploid cell culture | Human Rabies vaccine from human diploid cell culture |
| 176 | http://hl7.org/fhir/sid/cvx | Rabies - IM fibroblast culture | Human rabies vaccine from Chicken fibroblast culture |
| 177 | http://hl7.org/fhir/sid/cvx | PCV10 | pneumococcal conjugate vaccine, 10 valent |
| 178 | http://hl7.org/fhir/sid/cvx | OPV bivalent | Non-US bivalent oral polio vaccine (types 1 and 3) |
| 179 | http://hl7.org/fhir/sid/cvx | OPV ,monovalent, unspecified | Non-US monovalent oral polio vaccine, unspecified formulation |
| 180 | http://hl7.org/fhir/sid/cvx | tetanus immune globulin | tetanus immune globulin |
| 181 | http://hl7.org/fhir/sid/cvx | anthrax immune globulin | anthrax immune globulin |
| 182 | http://hl7.org/fhir/sid/cvx | OPV, Unspecified | Oral Polio Vaccine, Unspecified formulation |
| 183 | http://hl7.org/fhir/sid/cvx | Yellow fever vaccine live - alt | Yellow fever vaccine live - alternative formulation for vaccine shortage |
| 184 | http://hl7.org/fhir/sid/cvx | Yellow fever, unspecified | Yellow fever vaccine, unspecified formulation |
| 185 | http://hl7.org/fhir/sid/cvx | influenza, recombinant, quadrivalent,injectable, preservative free | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |
| 186 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, MDCK, quadrivalent, preservative | Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative |
| 187 | http://hl7.org/fhir/sid/cvx | zoster recombinant | zoster vaccine recombinant |
| 188 | http://hl7.org/fhir/sid/cvx | zoster, unspecified formulation | zoster vaccine, unspecified formulation |
| 189 | http://hl7.org/fhir/sid/cvx | HepB-CpG | Hepatitis B vaccine (recombinant), CpG adjuvanted |
| 190 | http://hl7.org/fhir/sid/cvx | Typhoid conjugate vaccine (TCV) | Typhoid conjugate vaccine (non-US) |
| 191 | http://hl7.org/fhir/sid/cvx | meningococcal A polysaccharide (non-US) | meningococcal A polysaccharide vaccine (non-US) |
| 192 | http://hl7.org/fhir/sid/cvx | meningococcal AC polysaccharide (non-US) | meningococcal AC polysaccharide vaccine (non-US) |
| 193 | http://hl7.org/fhir/sid/cvx | Hep A-Hep B, pediatric/adolescent | hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |
| 194 | http://hl7.org/fhir/sid/cvx | Influenza, Southern Hemisphere | influenza, Southern Hemisphere, unspecified formulation |
| 195 | http://hl7.org/fhir/sid/cvx | DT, IPV adsorbed | Diphtheria, Tetanus, Poliomyelitis adsorbed |
| 196 | http://hl7.org/fhir/sid/cvx | Td, adsorbed, preservative free, adult use, Lf unspecified | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |
| 197 | http://hl7.org/fhir/sid/cvx | influenza, high-dose, quadrivalent | influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free |
| 200 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, pediatric, preservative free | influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |
| 201 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, preservative free | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |
| 202 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, quadrivalent, with preservative | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |
| 198 | http://hl7.org/fhir/sid/cvx | DTP-hepB-Hib Pentavalent Non-US | Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |
| 203 | http://hl7.org/fhir/sid/cvx | meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) | meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free |
| 205 | http://hl7.org/fhir/sid/cvx | Influenza vaccine, quadrivalent, adjuvanted | influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free |
| 206 | http://hl7.org/fhir/sid/cvx | Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection | Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection |
| 207 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
| 208 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |
| 213 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
| 210 | http://hl7.org/fhir/sid/cvx | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |
| 212 | http://hl7.org/fhir/sid/cvx | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |
| 204 | http://hl7.org/fhir/sid/cvx | Ebola Zaire vaccine, live, recombinant, 1mL dose | Ebola Zaire vaccine, live, recombinant, 1mL dose |
| 214 | http://hl7.org/fhir/sid/cvx | Ebola, unspecified | Ebola, unspecified |
| 211 | http://hl7.org/fhir/sid/cvx | COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose |
| 500 | http://hl7.org/fhir/sid/cvx | COVID-19 Non-US Vaccine, Product Unknown | SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |
| 501 | http://hl7.org/fhir/sid/cvx | COVID-19 IV Non-US Vaccine (QAZCOVID-IN) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |
| 502 | http://hl7.org/fhir/sid/cvx | COVID-19 IV Non-US Vaccine (COVAXIN) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |
| 503 | http://hl7.org/fhir/sid/cvx | COVID-19 LAV Non-US Vaccine (COVIVAC) | SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |
| 504 | http://hl7.org/fhir/sid/cvx | COVID-19 VVnr Non-US Vaccine (Sputnik Light) | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |
| 505 | http://hl7.org/fhir/sid/cvx | COVID-19 VVnr Non-US Vaccine (Sputnik V) | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |
| 506 | http://hl7.org/fhir/sid/cvx | COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology |
| 507 | http://hl7.org/fhir/sid/cvx | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |
| 508 | http://hl7.org/fhir/sid/cvx | COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) |
| 509 | http://hl7.org/fhir/sid/cvx | COVID-19 PS Non-US Vaccine (EpiVacCorona) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |
| 510 | http://hl7.org/fhir/sid/cvx | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |
| 511 | http://hl7.org/fhir/sid/cvx | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |
| 215 | http://hl7.org/fhir/sid/cvx | Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF | Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free |
| 216 | http://hl7.org/fhir/sid/cvx | Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF | Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free |
| 219 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |
| 217 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |
| 218 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |
| 220 | http://hl7.org/fhir/sid/cvx | HepB recombinant, 3-antigen, Al(OH)3 | Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted |
| 221 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
| 222 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis, unspecified | Tick-borne encephalitis vaccine, unspecified |
| 223 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis, inactivated, PF, 0.25mL | Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose |
| 224 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis, inactivated, PF, 0.5mL | Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose |
| 225 | http://hl7.org/fhir/sid/cvx | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL | SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose |
| 226 | http://hl7.org/fhir/sid/cvx | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL | SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose |
| 512 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) | SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) |
| 513 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) |
| 514 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) | SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) |
| 515 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) |
| 516 | http://hl7.org/fhir/sid/cvx | COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) | SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
| 517 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) |
| 227 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose |
| 228 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose |
| 229 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose |
| 301 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation |
| 300 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation |
| 230 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose |
| 518 | http://hl7.org/fhir/sid/cvx | COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) | SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |
| 519 | http://hl7.org/fhir/sid/cvx | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna | SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |
| 520 | http://hl7.org/fhir/sid/cvx | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech | SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech |
| 521 | http://hl7.org/fhir/sid/cvx | COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK | SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK |
| 231 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, high-dose, quadrivalent | influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free |
| 303 | http://hl7.org/fhir/sid/cvx | RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF | Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free |
| 304 | http://hl7.org/fhir/sid/cvx | Respiratory syncytial virus (RSV), unspecified | Respiratory syncytial virus (RSV), unspecified |
| 305 | http://hl7.org/fhir/sid/cvx | RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF | Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free |
| 306 | http://hl7.org/fhir/sid/cvx | RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months | Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months |
| 307 | http://hl7.org/fhir/sid/cvx | RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months | Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months |
| 313 | http://hl7.org/fhir/sid/cvx | COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose |
| 308 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose |
| 309 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose |
| 310 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose |
| 312 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
| 311 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose |
| 315 | http://hl7.org/fhir/sid/cvx | Respiratory syncytial virus (RSV) MAB, unspecified | Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified |
| 314 | http://hl7.org/fhir/sid/cvx | Respiratory syncytial virus (RSV) vaccine, unspecified | Respiratory syncytial virus (RSV) vaccine, unspecified |
| 316 | http://hl7.org/fhir/sid/cvx | Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF | Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free |
| 317 | http://hl7.org/fhir/sid/cvx | Chikungunya live attenuated vaccine, 0.5 mL, PF | Chikungunya, live attenuated vaccine, 0.5 mL, preservative free |
| 318 | http://hl7.org/fhir/sid/cvx | Anthrax, post-exposure prophylaxis | Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis |
| 319 | http://hl7.org/fhir/sid/cvx | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified |
| 302 | http://hl7.org/fhir/sid/cvx | COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |